OpenURL Connection Search

Select item for more details and to access through your institution.

Phase I Clinical Trial Using [ 99m Tc]Tc-1-thio-D-glucose for Diagnosis of Lymphoma Patients.
Published in:
Pharmaceutics, 2022, v. 14, n. 6, p. 1274, doi. 10.3390/pharmaceutics14061274
By:
- Chernov, Vladimir;
- Dudnikova, Ekaterina;
- Zelchan, Roman;
- Medvedeva, Anna;
- Rybina, Anstasiya;
- Bragina, Olga;
- Goldberg, Viktor;
- Muravleva, Albina;
- Sörensen, Jens;
- Tolmachev, Vladimir
Publication type:
Article
Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with 99m Tc for Radionuclide Imaging of HER2 Expression in Cancer.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13443, doi. 10.3390/ijms232113443
By:
- Larkina, Mariia;
- Plotnikov, Evgenii;
- Bezverkhniaia, Ekaterina;
- Shabanova, Yulia;
- Tretyakova, Maria;
- Yuldasheva, Feruza;
- Zelchan, Roman;
- Schulga, Alexey;
- Konovalova, Elena;
- Vorobyeva, Anzhelika;
- Garousi, Javad;
- Gräslund, Torbjörn;
- Belousov, Mikhail;
- Tolmachev, Vladimir;
- Deyev, Sergey
Publication type:
Article
Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [ 99m Tc]Tc(CO) 3 -(HE) 3 -Ec1 for Visualization of EpCAM-Expressing Lung Cancer.
Published in:
Cancers, 2024, v. 16, n. 16, p. 2815, doi. 10.3390/cancers16162815
By:
- Zelchan, Roman;
- Chernov, Vladimir;
- Medvedeva, Anna;
- Rybina, Anastasia;
- Bragina, Olga;
- Mishina, Elizaveta;
- Larkina, Mariia;
- Varvashenya, Ruslan;
- Fominykh, Anastasia;
- Schulga, Alexey;
- Konovalova, Elena;
- Vorobyeva, Anzhelika;
- Orlova, Anna;
- Tashireva, Liubov;
- Deyev, Sergey M.;
- Tolmachev, Vladimir
Publication type:
Article
Phase I Trial of [ 99m Tc]Tc-maSSS-PEG 2 -RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors.
Published in:
Cancers, 2023, v. 15, n. 6, p. 1631, doi. 10.3390/cancers15061631
By:
- Chernov, Vladimir;
- Rybina, Anastasiya;
- Zelchan, Roman;
- Medvedeva, Anna;
- Bragina, Olga;
- Lushnikova, Nadejda;
- Doroshenko, Artem;
- Usynin, Evgeniy;
- Tashireva, Liubov;
- Vtorushin, Sergey;
- Abouzayed, Ayman;
- Rinne, Sara S.;
- Sörensen, Jens;
- Tolmachev, Vladimir;
- Orlova, Anna
Publication type:
Article
99mTc-labeled monosaccharide kits: development methods and quality control.
Published in:
Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-61707-7
By:
- Stasyuk, Elena;
- Sкuridin, Viktor;
- Rogov, Alexander;
- Zelchan, Roman;
- Sadkin, Vladimir;
- Varlamova, Natalya;
- Nestеrov, Evgeny
Publication type:
Article
Phase I trial of 99mTc-(HE)3-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262542
By:
- Bragina, Olga;
- Chernov, Vladimir;
- Schulga, Alexey;
- Konovalova, Elena;
- Garbukov, Eugeniy;
- Vorobyeva, Anzhelika;
- 2,6;, Anna Orlova;
- Tashireva, Liubov;
- Sörensen, Jens;
- Zelchan, Roman;
- Medvedeva, Anna;
- Deyev, Sergey;
- Tolmachev, Vladimir
Publication type:
Article
Phase I trial of 99mTc-(HE)3-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262542
By:
- Bragina, Olga;
- Chernov, Vladimir;
- Schulga, Alexey;
- Konovalova, Elena;
- Garbukov, Eugeniy;
- Vorobyeva, Anzhelika;
- Orlova, Anna;
- Tashireva, Liubov;
- Sörensen, Jens;
- Zelchan, Roman;
- Medvedeva, Anna;
- Deyev, Sergey;
- Tolmachev, Vladimir
Publication type:
Article
Phase I trial of 99mTc-(HE)3-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262542
By:
- Bragina, Olga;
- Chernov, Vladimir;
- Schulga, Alexey;
- Konovalova, Elena;
- Garbukov, Eugeniy;
- Vorobyeva, Anzhelika;
- Orlova, Anna;
- Tashireva, Liubov;
- Sörensen, Jens;
- Zelchan, Roman;
- Medvedeva, Anna;
- Deyev, Sergey;
- Tolmachev, Vladimir
Publication type:
Article
Phase I trial of 99mTc-(HE)3-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262542
By:
- Bragina, Olga;
- Chernov, Vladimir;
- Schulga, Alexey;
- Konovalova, Elena;
- Garbukov, Eugeniy;
- Vorobyeva, Anzhelika;
- Orlova, Anna;
- Tashireva, Liubov;
- Sörensen, Jens;
- Zelchan, Roman;
- Medvedeva, Anna;
- Deyev, Sergey;
- Tolmachev, Vladimir
Publication type:
Article
Phase I study of 99mTc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.248799
By:
- Bragina, Olga;
- von Witting, Emma;
- Garousi, Javad;
- Zelchan, Roman;
- Sandström, Mattias;
- Orlova, Anna;
- Medvedeva, Anna;
- Doroshenko, Artem;
- Vorobyeva, Anzhelika;
- Lindbo, Sarah;
- Borin, Jesper;
- Tarabanovskaya, Natalya;
- Sörensen, Jens;
- Hober, Sophia;
- Chernov, Vladimir;
- Tolmachev, Vladimir
Publication type:
Article
Phase I study of 99mTc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.248799
By:
- Bragina, Olga;
- von Witting, Emma;
- Garousi, Javad;
- Zelchan, Roman;
- Sandström, Mattias;
- Orlova, Anna;
- Medvedeva, Anna;
- Doroshenko, Artem;
- Vorobyeva, Anzhelika;
- Lindbo, Sarah;
- Borin, Jesper;
- Tarabanovskaya, Natalya;
- Sörensen, Jens;
- Hober, Sophia;
- Chernov, Vladimir;
- Tolmachev, Vladimir
Publication type:
Article
Phase I study of 99mTc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.248799
By:
- Bragina, Olga;
- Witting, Emma von;
- Garousi, Javad;
- Zelchan, Roman;
- Sandström, Mattias;
- Orlova, Anna;
- Medvedeva, Anna;
- Doroshenko, Artem;
- Vorobyeva, Anzhelika;
- Lindbo, Sarah;
- Borin, Jesper;
- Tarabanovskaya, Natalya;
- Sörensen, Jens;
- Hober, Sophia;
- Chernov, Vladimir;
- Tolmachev, Vladimir
Publication type:
Article
Phase I study of 99mTc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.248799
By:
- Bragina, Olga;
- von Witting, Emma;
- Garousi, Javad;
- Zelchan, Roman;
- Sandström, Mattias;
- Orlova, Anna;
- Medvedeva, Anna;
- Doroshenko, Artem;
- Vorobyeva, Anzhelika;
- Lindbo, Sarah;
- Borin, Jesper;
- Tarabanovskaya, Natalya;
- Sörensen, Jens;
- Hober, Sophia;
- Chernov, Vladimir;
- Tolmachev, Vladimir
Publication type:
Article
99mTc-labeled nanocolloid drugs: development methods.
Published in:
Scientific Reports, 2020, p. N.PAG, doi. 10.1038/s41598-020-70991-2
By:
- Sadkin, Vladimir;
- Sкuridin, Viktor;
- Nesterov, Evgeny;
- Stasyuk, Elena;
- Rogov, Alexander;
- Varlamova, Natalya;
- Zelchan, Roman
Publication type:
Article
The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer.
Published in:
Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102533
By:
- Li, Mei;
- Zelchan, Roman;
- Orlova, Anna
Publication type:
Article
The GRPR Antagonist [ 99m Tc]Tc-maSSS-PEG 2 -RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity.
Published in:
Diagnostics (2075-4418), 2023, v. 13, n. 9, p. 1611, doi. 10.3390/diagnostics13091611
By:
- Abouzayed, Ayman;
- Borin, Jesper;
- Lundmark, Fanny;
- Rybina, Anastasiya;
- Hober, Sophia;
- Zelchan, Roman;
- Tolmachev, Vladimir;
- Chernov, Vladimir;
- Orlova, Anna
Publication type:
Article
Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4858, doi. 10.7150/thno.86770
By:
- Bragina, Olga;
- Chernov, Vladimir;
- Larkina, Mariia;
- Rybina, Anstasiya;
- Zelchan, Roman;
- Garbukov, Eugeniy;
- Oroujeni, Maryam;
- Loftenius, Annika;
- Orlova, Anna;
- Sörensen, Jens;
- Frejd, Fredrik Y.;
- Tolmachev, Vladimir
Publication type:
Article

Found: 17

Phase I Clinical Trial Using [ 99m Tc]Tc-1-thio-D-glucose for Diagnosis of Lymphoma Patients.

Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with 99m Tc for Radionuclide Imaging of HER2 Expression in Cancer.

Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [ 99m Tc]Tc(CO) 3 -(HE) 3 -Ec1 for Visualization of EpCAM-Expressing Lung Cancer.

Phase I Trial of [ 99m Tc]Tc-maSSS-PEG 2 -RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors.

99mTc-labeled monosaccharide kits: development methods and quality control.

Phase I trial of <sup>99m</sup>Tc-(HE)3-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer.

Phase I trial of <sup>99m</sup>Tc-(HE)3-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer.

Phase I trial of <sup>99m</sup>Tc-(HE)<sub>3</sub>-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer.

Phase I trial of <sup>99m</sup>Tc-(HE)<sub>3</sub>-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer.

Phase I study of <sup>99m</sup>Tc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer.

Phase I study of <sup>99m</sup>Tc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer.

Phase I study of <sup>99m</sup>Tc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer.

Phase I study of <sup>99</sup>mTc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer.

<sup>99m</sup>Tc-labeled nanocolloid drugs: development methods.

The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer.

The GRPR Antagonist [ 99m Tc]Tc-maSSS-PEG 2 -RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity.

Phase I clinical evaluation of <sup>99m</sup>Tc-labeled Affibody molecule for imaging HER2 expression in breast cancer.